Thanks for taking the time to visit my JustGiving page.

Donating through JustGiving is simple, fast and totally secure. Your details are safe with JustGiving - they'll never sell them on or send unwanted emails. Once you donate, they'll send your money directly to the charity. So it's the most efficient way to donate - saving time and cutting costs for the charity.

NOW TO THE STORY:

On Sunday 17th September six intrepid heroes from the Stephen Perse Foundation faced a foggy early morning start to take part in the 2017 Cambridge charity event known as "Chariots of Fire."

First held in 1992, the race is one of Cambridgeshire’s largest annual charity events. Teams of six each run a 1.6 mile course through Cambridge’s iconic City centre in relay format, crossing the river Cam next to famous landmarks such as the Mathematical bridge, and passing by King’s College Chapel. This year’s team hope to raise as much as possible for this year's run chosen charity: Alzheimer's Research UK.

The team members managed an impressive 55th placing in the event, out of a total of 334 teams, in a total time of 1 hour 9 minutes and 11 seconds. They were 5th in their category of ‘Male Veterans’.

Starting the line up was David "Let's hope that he does better than his surname" Walker, followed by Ignazio “600 yards gold medalist” Pompeo, who handed smoothly to Simon "Boom Boom" Tustin, passing on to Ben "Golden Legs" Keeble, handing over to Tim "The gazelle of the Fens" Pegler, transferring to Paul Carter "USM" (Unstoppable Speedy Machine) for the final leg.

Alzheimer’s Research UK is the UK’s leading dementia research charity. Their vision is to create a world free from the fear, harm and heartbreak of dementia, and to achieve this they fund world-class research at universities and centres across the UK. Their funding has helped to discover over 21 risk genes for Alzheimer’s, unlocking new avenues for research. Their team of Cambridge scientists have pioneered cutting-edge new stem cell approaches to studying Alzheimer’s and screening new drugs, and the charity is committed to funding research with the greatest potential to benefit those living with dementia and their
families.